dose of digital fda pharma social media hearing testimony - adverse event reporting

Post on 05-Dec-2014

2.327 Views

Category:

Business

0 Downloads

Preview:

Click to see full reader

DESCRIPTION

This is my testimony that I will present to the FDA at the upcoming hearings on the use of social communications in pharma. This specifically will address their question regarding adverse event monitoring and reporting

TRANSCRIPT

Are pharma companies supposed to be private investigators?

Jonathan RichmanDirector of Strategic Planning, Bridge WorldwideAuthor, Dose of Digital

Required for reporting:

1. an identifiable patient2. an identifiable reporter3. a specific drug or biologic involved in the

event4. an adverse event or fatal outcome

Only 1 in 500 posts have all this info.

Is this a reportable adverse event?

1. An Identifiable Patient

Is this “identifiable”?

1. An Identifiable Patient

1. An Identifiable Patient

2. An Identifiable Reporter

2. An Identifiable Reporter

3. a specific drug involved in the event

I can't remember the name it was something with a R. I got the shakes so bad that I had to take beta blockers to stop them.

I can't remember the name it was something with a R. I got the shakes so bad that I had to take beta blockers to stop them.

4. An adverse or fatal outcome

I ‘m beginning to wonder if the Parkinson-like movement of my left hand is related to taking Lipitor

I ‘m beginning to wonder if the Parkinson-like movement of my left hand is related to taking Lipitor

In the “Old Days”...

A New Reality1

1. an identifiable patient2. an identifiable reporter3. a specific drug or biologic involved in the event4. an adverse event or fatal outcome

23

4

A New Reality

HealthGuy

New Guidance Needed?

1. an identifiable patient2. an identifiable reporter3. a specific drug or biologic involved in the

event4. an adverse event or fatal outcome

New Guidance Needed?

2. an identifiable reporter

New Guidance Needed?

New Guidance Needed?

1. an identifiable patient2. an identifiable reporter3. a specific drug or biologic involved in the

event4. an adverse event or fatal outcome

Jonathan RichmanDirector of Strategic Planning, Bridge WorldwideAuthor, Dose of Digital

top related